News Release
Mallinckrodt to Present at Leerink Swann Global Healthcare Conference
DUBLIN--(BUSINESS WIRE)--Feb. 5, 2014--
Mallinckrodt
plc (NYSE: MNK), a global specialty pharmaceutical and global medical
imaging company, will present at the Leerink Swann Global Healthcare
Conference in New York on February 13, 2014. The senior management of
Mallinckrodt will participate in a fireside chat scheduled to begin at
10:45AM EST.
A live audio webcast of the presentation can be accessed at
Mallinckrodt’s Investor Relations website: http://mallinckrodt.com/investor_relations.
A replay will be available on the website following the conclusion of
the meeting.
ABOUT MALLINCKRODT:
Mallinckrodt is a global specialty pharmaceutical and medical imaging
business that develops, manufactures, markets and distributes specialty
pharmaceutical products and medical imaging agents. The company’s
Specialty Pharmaceuticals segment includes branded and generic drugs and
active pharmaceutical ingredients, and the Global Medical Imaging
segment includes contrast media and nuclear imaging agents. Mallinckrodt
has approximately 5,500 employees worldwide and a commercial presence in
roughly 70 countries. The company’s fiscal 2013 revenue totaled $2.2
billion. To learn more about Mallinckrodt, visit www.mallinckrodt.com.
Source: Mallinckrodt
Mallinckrodt
John Moten, 314-654-6650
Vice President, Investor
Relations
john.moten@mallinckrodt.com
or
Lynn
Phillips, 314-654-3263
Manager, Media Relations
lynn.phillips@mallinckrodt.com
